Your browser doesn't support javascript.
loading
GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis.
Guttman-Yassky, Emma; Pavel, Ana B; Zhou, Lisa; Estrada, Yeriel D; Zhang, Ning; Xu, Hui; Peng, Xiangyu; Wen, Huei-Chi; Govas, Panayiota; Gudi, Girish; Ca, Vinu; Fang, Hui; Salhi, Yacine; Back, Jonathan; Reddy, Venkateshwar; Bissonnette, Robert; Maari, Catherine; Grossman, Fred; Wolff, Gerhard.
Afiliación
  • Guttman-Yassky E; Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: emma.guttman@mountsinai.org.
  • Pavel AB; Icahn School of Medicine at Mount Sinai, New York, NY.
  • Zhou L; Icahn School of Medicine at Mount Sinai, New York, NY.
  • Estrada YD; Icahn School of Medicine at Mount Sinai, New York, NY.
  • Zhang N; Icahn School of Medicine at Mount Sinai, New York, NY.
  • Xu H; Icahn School of Medicine at Mount Sinai, New York, NY.
  • Peng X; Icahn School of Medicine at Mount Sinai, New York, NY.
  • Wen HC; Icahn School of Medicine at Mount Sinai, New York, NY.
  • Govas P; Icahn School of Medicine at Mount Sinai, New York, NY.
  • Gudi G; Glenmark Pharmaceuticals, Inc, Paramus, NJ.
  • Ca V; Glenmark Pharmaceuticals, Ltd, Mumbai, India.
  • Fang H; Glenmark Pharmaceuticals, Inc, Paramus, NJ.
  • Salhi Y; Glenmark Pharmaceuticals, Inc, Paramus, NJ.
  • Back J; Glenmark Pharmaceuticals, SA, La Chaux-de-Fonds, Switzerland.
  • Reddy V; Glenmark Pharmaceuticals, Inc, Paramus, NJ.
  • Bissonnette R; Inovaderm Research, Montreal, Quebec, Canada.
  • Maari C; Inovaderm Research, Montreal, Quebec, Canada.
  • Grossman F; Glenmark Pharmaceuticals, Inc, Paramus, NJ.
  • Wolff G; Glenmark Pharmaceuticals, Inc, Paramus, NJ.
J Allergy Clin Immunol ; 144(2): 482-493.e7, 2019 08.
Article en En | MEDLINE | ID: mdl-30738171
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Piel / Regulación de la Expresión Génica / Citocinas / Dermatitis Atópica / Receptores OX40 / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Piel / Regulación de la Expresión Génica / Citocinas / Dermatitis Atópica / Receptores OX40 / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Año: 2019 Tipo del documento: Article